語系:
繁體中文
English
說明(常見問題)
登入
回首頁
切換:
標籤
|
MARC模式
|
ISBD
An Introduction to Bioanalysis of Biopharmaceuticals
紀錄類型:
書目-語言資料,印刷品 : Monograph/item
正題名/作者:
An Introduction to Bioanalysis of Biopharmaceuticals/ edited by Seema Kumar.
其他作者:
Kumar, Seema.
面頁冊數:
IX, 160 p. 25 illus., 19 illus. in color.online resource. :
Contained By:
Springer Nature eBook
標題:
Cell Biology. -
電子資源:
https://doi.org/10.1007/978-3-030-97193-9
ISBN:
9783030971939
An Introduction to Bioanalysis of Biopharmaceuticals
An Introduction to Bioanalysis of Biopharmaceuticals
[electronic resource] /edited by Seema Kumar. - 1st ed. 2022. - IX, 160 p. 25 illus., 19 illus. in color.online resource. - AAPS Advances in the Pharmaceutical Sciences Series,572210-738X ;. - AAPS Advances in the Pharmaceutical Sciences Series,20.
Bioanalytical Support in Drug Discovery and Development,- Monoclonal Antibodies -- Antibody Drug Conjugates (ADCS) -- Bispecifics and Fusion Proteins -- Emerging Modalities-Part A- (Gene Therapy and Cell Therapy) -- Emerging Modalities Part B (Peptides, Oligonucleotide Based Therapy, Vaccines. .
The book provides a comprehensive review of the fundamental and practical aspects of bioanalytical support and the integral role it plays in the development of safe and efficacious biopharmaceutical drugs with speed and cost-effectiveness. The book focuses on a broad range of conventional and emerging biopharmaceutical modalities including monoclonal antibody-based therapeutics, gene therapy, cell therapy, peptides and oligonucleotides. The book starts with an introductory overview of bioanalysis showcasing the integral role it plays in understanding the drug disposition (pharmacokinetics/pharmacodynamics and immunogenicity) and the progression of bioanalytical strategy as the drug progresses through discovery and development stages of the program, taking into consideration the continually evolving regulatory landscape. The book further diversifies into individual biopharmaceutical modalities - monoclonal antibodies, antibody-drug conjugates, bispecifics, Fc-fusion proteins, gene therapies, cell therapies, peptides and oligonucleotides. The individual chapters focus on modality-specific bioanalytical assay strategies, critical reagents, assay formats, analytical platforms, associated bioanalytical challenges and mitigation strategies, industry best practices, and the latest understanding of regulatory guidance as applicable to the fast-growing biopharmaceutical landscape.
ISBN: 9783030971939
Standard No.: 10.1007/978-3-030-97193-9doiSubjects--Topical Terms:
593889
Cell Biology.
LC Class. No.: QH301-705
Dewey Class. No.: 570
An Introduction to Bioanalysis of Biopharmaceuticals
LDR
:03140nam a22004095i 4500
001
1082279
003
DE-He213
005
20220823133540.0
007
cr nn 008mamaa
008
221228s2022 sz | s |||| 0|eng d
020
$a
9783030971939
$9
978-3-030-97193-9
024
7
$a
10.1007/978-3-030-97193-9
$2
doi
035
$a
978-3-030-97193-9
050
4
$a
QH301-705
072
7
$a
PSA
$2
bicssc
072
7
$a
SCI086000
$2
bisacsh
072
7
$a
PSA
$2
thema
082
0 4
$a
570
$2
23
245
1 3
$a
An Introduction to Bioanalysis of Biopharmaceuticals
$h
[electronic resource] /
$c
edited by Seema Kumar.
250
$a
1st ed. 2022.
264
1
$a
Cham :
$b
Springer International Publishing :
$b
Imprint: Springer,
$c
2022.
300
$a
IX, 160 p. 25 illus., 19 illus. in color.
$b
online resource.
336
$a
text
$b
txt
$2
rdacontent
337
$a
computer
$b
c
$2
rdamedia
338
$a
online resource
$b
cr
$2
rdacarrier
347
$a
text file
$b
PDF
$2
rda
490
1
$a
AAPS Advances in the Pharmaceutical Sciences Series,
$x
2210-738X ;
$v
57
505
0
$a
Bioanalytical Support in Drug Discovery and Development,- Monoclonal Antibodies -- Antibody Drug Conjugates (ADCS) -- Bispecifics and Fusion Proteins -- Emerging Modalities-Part A- (Gene Therapy and Cell Therapy) -- Emerging Modalities Part B (Peptides, Oligonucleotide Based Therapy, Vaccines. .
520
$a
The book provides a comprehensive review of the fundamental and practical aspects of bioanalytical support and the integral role it plays in the development of safe and efficacious biopharmaceutical drugs with speed and cost-effectiveness. The book focuses on a broad range of conventional and emerging biopharmaceutical modalities including monoclonal antibody-based therapeutics, gene therapy, cell therapy, peptides and oligonucleotides. The book starts with an introductory overview of bioanalysis showcasing the integral role it plays in understanding the drug disposition (pharmacokinetics/pharmacodynamics and immunogenicity) and the progression of bioanalytical strategy as the drug progresses through discovery and development stages of the program, taking into consideration the continually evolving regulatory landscape. The book further diversifies into individual biopharmaceutical modalities - monoclonal antibodies, antibody-drug conjugates, bispecifics, Fc-fusion proteins, gene therapies, cell therapies, peptides and oligonucleotides. The individual chapters focus on modality-specific bioanalytical assay strategies, critical reagents, assay formats, analytical platforms, associated bioanalytical challenges and mitigation strategies, industry best practices, and the latest understanding of regulatory guidance as applicable to the fast-growing biopharmaceutical landscape.
650
2 4
$a
Cell Biology.
$3
593889
650
2 4
$a
Biological Chemistry.
$3
1387889
650
2 4
$a
Pharmaceutics.
$3
1366841
650
1 4
$a
Biological Sciences.
$3
790542
650
0
$a
Cytology.
$3
599554
650
0
$a
Pharmacology.
$3
583819
650
0
$a
Biochemistry.
$3
582831
650
0
$a
Pharmaceutical chemistry.
$3
581965
650
0
$a
Biology.
$3
599573
700
1
$a
Kumar, Seema.
$e
editor.
$4
edt
$4
http://id.loc.gov/vocabulary/relators/edt
$3
1387888
710
2
$a
SpringerLink (Online service)
$3
593884
773
0
$t
Springer Nature eBook
776
0 8
$i
Printed edition:
$z
9783030971922
776
0 8
$i
Printed edition:
$z
9783030971946
776
0 8
$i
Printed edition:
$z
9783030999988
830
0
$a
AAPS Advances in the Pharmaceutical Sciences Series,
$x
2210-7371 ;
$v
20
$3
1255084
856
4 0
$u
https://doi.org/10.1007/978-3-030-97193-9
912
$a
ZDB-2-SBL
912
$a
ZDB-2-SXB
950
$a
Biomedical and Life Sciences (SpringerNature-11642)
950
$a
Biomedical and Life Sciences (R0) (SpringerNature-43708)
筆 0 讀者評論
多媒體
評論
新增評論
分享你的心得
Export
取書館別
處理中
...
變更密碼[密碼必須為2種組合(英文和數字)及長度為10碼以上]
登入